(Q46686630)

24 December 2017

title

Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients (English)

1 reference

24 December 2017

1 reference

1 reference

Vassilios Liakopoulos

2

1 reference

24 December 2017

author name string

Georgios Filippidis

1

1 reference

24 December 2017

Peter Rene Mertens

3

1 reference

24 December 2017

Theodoros Kiropoulos

4

1 reference

24 December 2017

Nikolaos Stakias

5

1 reference

24 December 2017

Christina Verikouki

6

1 reference

24 December 2017

Eftichios Patsidis

7

1 reference

24 December 2017

Georgios Koukoulis

8

1 reference

24 December 2017

Ioannis Stefanidis

9

1 reference

24 December 2017

publication date

2 September 2005

1 reference

24 December 2017

published in

Blood Purification

1 reference

24 December 2017

volume

23

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

421-428

1 reference

24 December 2017

The hormone resistin links obesity to diabetes

cites work

1 reference

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

21 January 2018

1 reference

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

21 January 2018

1 reference

The role of the novel adipocyte-derived hormone adiponectin in human disease

21 January 2018

1 reference

Assays for insulin, proinsulin(s) and C-peptide

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

HOMA index to assess insulin resistance in renal failure patients.

21 January 2018

1 reference

Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity

21 January 2018

1 reference

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

Resistin and obesity-associated insulin resistance

21 January 2018

1 reference

Increased resistin blood levels are not associated with insulin resistance in patients with renal disease

21 January 2018

1 reference

The current biology of resistin

21 January 2018

1 reference

Role of resistin in diet-induced hepatic insulin resistance

21 January 2018

1 reference

Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality.

21 January 2018

1 reference

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

Plasma adiponectin concentration before and after successful kidney transplantation

21 January 2018

1 reference

Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease

21 January 2018

1 reference

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors

21 January 2018

1 reference

Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal disease

21 January 2018

1 reference

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

21 January 2018

1 reference

Differences in mRNA expression of adipocyte-derived factors in response to fasting, refeeding and leptin.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000088017

1 reference

24 December 2017

1 reference

24 December 2017